Skip to content

Clinical trials

Phase 3 Opioid-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Opioid-Related Disorders Phase: Phase 3 Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20021
20032
20041
20053
20065
20074
20086
20095
20105
20112
20122
20134
20143
20157
20163
20176
20194
20203
20214
20234
20246
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66
Recruiting8
Terminated8
Active, not recruiting5
Withdrawn4
Unknown status4
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Titan Pharmaceuticals7
Yale University7
University of California, Los Angeles6
Alkermes, Inc.5
Butler Hospital5
New York State Psychiatric Institute5
Friends Research Institute, Inc.4
Indivior Inc.3
University of British Columbia3
University of Pennsylvania3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Opioid-Related Disorders98
Substance-Related Disorders13
Heroin Dependence7
Chronic Pain6
Substance Withdrawal Syndrome5
Alcoholism3
Cocaine-Related Disorders2
HIV Infections2
Morphine Dependence2
Narcotic-Related Disorders2

Trials

Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.